Barinib Tablet 2 mg contains Baricitinib, an oral Janus kinase (JAK) inhibitor designed for the treatment of moderate to severe rheumatoid arthritis (RA) and other autoimmune inflammatory conditions. This lower-dose formulation is ideal for patients requiring dose adjustments due to age, kidney function, or tolerability, while still providing effective control of inflammation and autoimmune activity.
Baricitinib works by targeting specific pathways in the immune system to reduce inflammation, alleviate joint pain, and prevent further joint damage, helping patients maintain mobility and improve quality of life.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Baricitinib, the active ingredient in Barinib Tablet, inhibits JAK1 and JAK2 enzymes, which play a crucial role in cytokine signaling responsible for inflammation. Key mechanisms include:
Blocking Pro-inflammatory Signals: Reduces the activity of cytokines that trigger swelling, pain, and tissue damage in autoimmune disorders.
Decreasing Immune Overactivity: Helps control abnormal immune responses that lead to joint erosion and stiffness.
Slowing Disease Progression: By controlling inflammation, Baricitinib prevents further damage to joints and soft tissues.
Through these mechanisms, Barinib Tablet 2 mg effectively manages symptoms while minimizing disease progression.
Barinib Tablet 2 mg is indicated for:
Moderate to severe rheumatoid arthritis: Especially in patients who have an inadequate response or intolerance to conventional DMARDs like methotrexate.
Autoimmune inflammatory conditions: Prescribed by a physician for patients requiring immune modulation with careful dose adjustment.
This lower-dose tablet is suitable for adults, particularly elderly patients or those with mild to moderate kidney impairment, and should always be taken under medical supervision.
Recommended Dose: 2 mg orally once daily, with or without food.
Swallow the tablet whole with water; do not crush, split, or chew.
Maintain a consistent dosing schedule to achieve optimal therapeutic effects.
Dose adjustments may be necessary for patients with reduced kidney function, liver impairment, or other comorbidities.
Regular monitoring of blood counts, liver function, and lipid profile is advised during treatment.
Reduces joint pain, swelling, and stiffness
Improves mobility and functional capacity
Slows progression of joint damage
Convenient once-daily oral dose for easy adherence
Provides a flexible lower-dose option for sensitive populations or dose-adjusted therapy
Barinib Tablet 2 mg is generally well tolerated. Some potential side effects include:
Upper respiratory tract infections
Nausea or headache
Mild fatigue or dizziness
Changes in blood counts, liver enzymes, or cholesterol levels
Rarely, serious infections or thromboembolic events
Patients should report persistent fever, unusual bruising, signs of infection, or severe side effects promptly to their physician.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Avoid in patients with known hypersensitivity to Baricitinib.
Use caution in patients with active infections, tuberculosis, or chronic liver or kidney disease.
Live vaccines should be avoided during therapy unless approved by a healthcare provider.
Pregnant or breastfeeding women should only use Baricitinib under strict medical supervision.
Always inform your healthcare provider of other medications to avoid potential drug interactions.
Store below 30°C in a cool, dry place, protected from light and moisture. Keep out of reach of children.
Barinib Tablet 2 mg (Baricitinib) offers an effective, safe, and convenient lower-dose therapy for managing moderate to severe rheumatoid arthritis, controlling inflammation, and preserving joint function under proper medical supervision.
Login Or Registerto submit your questions to seller
No none asked to seller yet